ArticleThe Lancet. Microbe2020

Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.

Catherine A Chappell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.